Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases

• Main Authors: Tadolini, M, Codecasa, LR, García-García, JM, Blanc, FX, Borisov, S, Alffenaar, JW, Andréjak, C, Bachez, P, Bart, PA, Belilovski, E, Cardoso-Landivar, J, Centis, R, D’Ambrosio, L, De Souza-Galvão, ML, Dominguez-Castellano, A, Dourmane, S, Jachym, MF, Froissart, A, Giacomet, V, Goletti, D, Grard, S, Gualano, G, Izadifar, A, Le Du, D, Royo, MM, Mazza-Stalder, J, Motta, I, Min Ong, CW, Palmieri, F, Rivière, F, Rodrigo, T, Silva, DR, Sánchez-Montalvá, A, Saporiti, M, Scarpellini, P, Schlemmer, F, Spanevello, A, Sumarokova, E, Tabernero, E, Tambyah, PA, Tiberi, S, Torre, A, Visca, D, Murguiondo, MZ, Sotgiu, G, Migliori, GB
• Other Authors: MEDICINE
• Format: Letter
• Published: European Respiratory Society (ERS) 2022
• Subjects: Adult; Aged; Antitubercular Agents; Antiviral Agents; Azithromycin; Betacoronavirus; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Cohort Studies; Coinfection; Coronavirus Infections; Drug Combinations; Emigrants and Immigrants; Female; Humans; Hydroxychloroquine; Lopinavir; Lung; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis, Pulmonary
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/216656
• Institution: National University of Singapore

10.1183/13993003.01398-2020